SlideShare a Scribd company logo
1 of 37
R A C H E L P R Y O R
E P I D 6 9 1
F E B R U A R Y 2 5 , 2 0 1 3
Asthma and COPD
What is asthma?
 Disorder of the airways
causing swelling and
narrowing; which leads
to wheezing, shortness of
breath, chest tightness,
and coughing
 Most common asthma
triggers: dust, animal
dander, weather changes,
pollution, mold, pollen,
respiratory infections,
stress, tobacco smoke
 There is no cure for
asthma.
 http://www.ncbi.nlm.nih.gov/pubmedhe
alth/PMH0001196/
Four categories of asthma
 According to the National
Heart, Lung, and Blood
Institute the four categories
are:
 1. Intermittent - daytime
symptoms that occur less
than two times/week and
nighttime symptoms occur
less than two times/month.
Normal pulmonary function
tests (PFT).
 2. Mild persistent - daytime
symptoms occurring two or
more times/week and
nighttime symptoms
occurring two or more
times/month. Normal PFT.
 http://virginiaasthmacoalition.org/documen
ts/AsthmaPlan.8.30.10.pdf
 3. Moderate persistent - daily daytime
symptoms and at least one weekly nighttime
symptom, and/or PFT reduced to 60 – 80%
of normal.
 4. Severe persistent - continuous daytime
symptoms and frequent night symptoms and
PFT that may be less than 60% of normal.
 National Heart, Lung, and Blood Institute, National Asthma Education
and Prevention Program (2007). Expert Panel Report 3: Guidelines for
the Diagnosis and Management of Asthma.
http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
Asthma: Incidence and Prevalence
 18.9 million adults, or 8.2% of the adult population, in
the U.S. have asthma
 7.1 million children, or 9.5% of children, in the U.S. have
asthma
 http://www.cdc.gov/nchs/fastats/asthma.htm
 Incidence of asthma in adults is 3.8/1000 at-risk adults
 Incidence of asthma in children is 12.5/1000 at-risk
children
 Among children 0-4 years old, incidence is 23.4/1000 children!
 Winer, Rachel A., Xiaoting Qin, B.A., Harrington, Theresa, Moorman, Jeanne, Zahran, Hatice.
Asthma Incidence among Children and Adults: Findings from the Behavioral Risk Factor
Surveillance System Asthma Call-back Survey—United States, 2006–2008. Asthma, February
2012, Vol. 49, No. 1 , Pages 16-22 (doi:10.3109/02770903.2011.637594).
What is “at-risk”?
Asthma Prevalence by Race/Ethnicity
 http://www.cdc.gov/mmwr/preview/mmwrhtml/su6001a18.htm?s_cid=su6001a18_w#tab
Asthma Prevalence by Sex and Race
Asthma Prevalence by SES and Race
More statistics
 Number of deaths caused by asthma (in 2010):
3,404
 1.1/100,000 of the population
 Number of outpatient visits per year with asthma
as primary diagnosis (in 2009): 1.2 million
 Number of ED visits with asthma as primary
diagnosis (in 2009): 2.1 million
 Number of hospital discharges with asthma as
first-listed diagnosis (in 2009): 479,000
 Average length of stay: 4.3 days
 http://www.cdc.gov/nchs/fastats/asthma.htm
The incidence of asthma is increasing
 From 2001 – 2009, the incidence of asthma increased by
4.3 million
 Rates grew the most (almost a 50% increase!) among black
children
 Why?
 Hygiene hypothesis: we’re “too clean”
 Sedentary lifestyle: decreases lung strength
 Obesity: increases overall inflammatory response of the human body
 Changes in immune system as we “modernize”
 http://www.scientificamerican.com/article.cfm?id=why-are-asthma-rates-soaring
The cost of asthma
 Medical expenses per
person per year is $3300
on average.
 40% of uninsured people
could not afford their
asthma-related
medications, and 11% of
insured people could not
afford their asthma-
related medications
between 2002-2007.
 Asthma costs in the US
in 2002 were
approximately $53
billion – in 2007 they
were approximately $56
billion.
 59% of children and 33%
of adults with asthma
missed school or work
due to asthma in 2008.
 On average, children
missed 4 days of school
and adults missed 5 days
of work because of asthma
 http://www.cdc.gov/VitalSigns/Asthma/i
ndex.html
Asthma and Public Health
 There are many public health initiatives in place to
reduce asthma exacerbations
 Community Preventative Services Task Force’s
initiative “Asthma Control: Home Based Multi
Trigger, Multicomponent Environmental
Interventions”
 Home visits are conducted by a trained person to assess home
environments and educate families about what can be done to
decrease asthma triggers and also how to better self-manage
one’s asthma
 http://www.thecommunityguide.org/asthma/multicomponent.html
Public Health Initiatives cont.
 Healthy People 2020 goal: “Promote respiratory
health through better prevention, detection,
treatment, and education efforts”
 Specific objectives:
http://www.healthypeople.gov/2020/topicsobjectives2020/o
bjectiveslist.aspx?topicId=36
 “Increase the number of States, Territories, and the District of
Columbia with a comprehensive asthma surveillance system for
tracking asthma cases, illness, and disability at the State level”
 No Virginia data on the CDC website!
http://www.cdc.gov/asthma/stateprofiles.htm
 http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=36
 In 2008, less than half of the people
diagnosed with asthma reported being
taught how to avoid triggers.
 48% of adults who were taught about
trigger avoidance did not follow most of
their doctor’s teaching.
 http://www.cdc.gov/VitalSigns/Asthma/index.html#StateInfo
Asthma in Virginia
 In 2010, the Virginia Asthma Coalition released a
plan for Virginia
 And VDH does track Virginia data (though the last
comprehensive report was written in 2007, using
data through 2004)
 7.3% of adults (412,370 people) in Virginia have
asthma
 9% of children (152,277 people) in Virginia have
asthma
 In 2004, total cost of asthma hospitalizations in
Virginia was $96 million! (which was a 58% increase
from 1999)
 https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
Asthma in Virginia
 Current
asthma
rates in
Virginia
have slightly
increased
since 2000
(average in
2000 was
7.1%, in
2008 it was
9.3%)
https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
Virginia compared to the US
https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
Virginia Stats
https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
Virginia Stats
https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
Research Needs
 According to the EPA, some of the most important
areas of research related to asthma include:
 More information about the induction and exacerbation of
asthma
 Why the incidence of asthma is increasing
 What factors make one more susceptible to asthma
 Risk assessment of environmental pollutants and asthma
 http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=54825
What is COPD?
 COPD is Chronic Obstructive Pulmonary Disease
and is characterized by diseases that cause airflow
blockage and problems related to breathing.
 It includes emphysema, chronic bronchitis, and
asthma (in some cases).
 COPD is caused by:
 Tobacco exposure
 Asthma
 Air pollutants
 Genetic factors
 Respiratory infections
 http://www.cdc.gov/copd/
Chronic bronchitis vs. emphysema
 Chronic
bronchitis is
characterized
by a long-term
cough with
mucous
production
 Emphysema is
characterized
by destruction
of the lungs
overtime
COPD: Prevalence
 There is a vast under-diagnosis of COPD.
 6.3% of American adults (approximately 15 million
people) have been diagnosed with COPD.
 In adults aged 18-44, 3.2% of the population has been
diagnosed with COPD.
 In adults ages 65 and older, 11.6% have been diagnosed
with COPD.
 White adults have the highest rate of COPD (6.3%).
 6.1% of black adults and 4.3% of Hispanic adults have
COPD.
 9.5% of those with COPD did not have a high school
diploma
 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm#fig
• In 2008, 9.8 million adults were diagnosed with chronic
bronchitis.
• In 2008, 3.8 million adults reported having ever been
diagnosed with emphysema.
• Surprisingly (to me), more women than men suffer from
these diseases.
• http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
Age-adjusted prevalence of COPD among adults
COPD in Virginia
 Chronic bronchitis is the second leading hospital
discharge diagnosis in Virginia.
 Emphysema is the seventh leading hospital diagnosis
in Virginia.
 http://www.vapremier.com/index.php?page=copd-management-program
Respiratory Disease Deaths in Virginia
Morbidity and mortality
 The estimated cost of COPD in 2010 was $49.9
billion.
 $29.5 billion related to direct hospital costs, $8 billion on
indirect morbidity costs, and $12.4 billion on indirect
mortality costs
 COPD is the third leading cause of death in the USA,
claiming 124,477 lives in 2007.
 672,000 hospitalizations in 2006 were due to COPD.
 http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html
Disparities and COPD
 More Caucasians than
African Americans have
chronic bronchitis (50.8
per 1000 vs. 38.6 per
1000).
 Rate among Hispanics
only 20.6 per 1000.
 The same is true of
emphysema (21.1 per 1000
Caucasians vs. 8.1 per 1000
African Americans vs. 6.3
per 1000 Hispanics)
 Among the uninsured,
African Americans were
significantly less likely than
Caucasians to receive a
lung transplant (61 vs 68%)
 50.5 per 100,000 White
men died from COPD in
2006
 Death rate for White
women was 39.1 per
100,000
 Death rate for Black men
was 37.7 per 100,000
 Death rate for Black
women was 18.9 per
100,000
 http://www.lung.org/assets/documents/
publications/solddc-chapters/copd.pdf
Public Health Research and COPD
 Access to healthcare is a huge obstacle for Hispanics
who suffer from COPD
 Studies who that they are twice as likely as Caucasians to
utilize the ER for management of their COPD
 Words such as wheeze and dyspnea do not translate well into
Spanish
 Hispanics are often grouped all together, rather than being
treated as people from various countries
 More research needs to be done to define subgroups of
Hispanics and their relationship to the healthcare system in
the United States
 http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
Public Health Research and COPD
 Very limited information has been collected about
Asian Americans, Native Americans, and Native
Pacific Islanders and the prevalence of COPD among
these groups
 http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
Healthy People 2020 and COPD
 Reduce activity limitations among adults with
chronic obstructive pulmonary disease (COPD)
 Reduce deaths from chronic obstructive pulmonary
disease (COPD) among adults
 Reduce hospitalizations for chronic obstructive
pulmonary disease (COPD)
 Reduce emergency department (ED) visits for
chronic obstructive pulmonary disease (COPD)
 Increase the proportion of adults with abnormal lung
function whose underlying obstructive disease has
been diagnosed
 http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=36
COPD Asthma
 Rarely occurs before age 45
 Rarely occurs in a non-
smoker
 Little can be done to
improve sx. of COPD once
patients experience them
 COPD patients rarely go a
day without experiencing
sx.
 Lung function never
returns to normal
 Can occur with asthma
 Can occur at any age
 Can occur in a smoker or
non-smoker
 Removing environmental
triggers can greatly
improve asthmatic sx.
 Asthmatics can go great
lengths of time in
between experiencing sx.
 Lung function returns to
normal between attacks
Asthma vs. COPD
COPD is often misdiagnosed as asthma, which leads to ineffective treatment and
management. (http://copd.about.com/od/fa1/a/asthmaorcopd.htm)
SMOKING CESSATION IS KEY!
 85 to 90% of COPD deaths are caused by smoking.
 Smokers are 12% (in men) and 13% (in women) more
likely to die from COPD than non-smokers.
 http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html
 Smokers likelihood of developing COPD is 50%.
 Risk of COPD decreased by 50% after quitting
smoking.
 Laniado-Laborín, Rafael . Smoking and Chronic Obstructive Pulmonary Disease (COPD): Parallel
Epidemics of the 21st Century. International Journal of Environmental Research and Public
Health, 2009, 6, 209-224; doi:10.3390/ijerph6010209.
Questions?

More Related Content

Similar to rachelslides.ppt

2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制 2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制
None
 
In the year 1900, the maximum number of deaths occurred due to infec.pdf
In the year 1900, the maximum number of deaths occurred due to infec.pdfIn the year 1900, the maximum number of deaths occurred due to infec.pdf
In the year 1900, the maximum number of deaths occurred due to infec.pdf
ankitcom
 
issuebrief_SanchezGerald
issuebrief_SanchezGeraldissuebrief_SanchezGerald
issuebrief_SanchezGerald
Gerald Sanchez
 
Prevalência e MI por CC na Europa de 2000 a 2005
Prevalência e MI por CC na Europa de 2000 a 2005Prevalência e MI por CC na Europa de 2000 a 2005
Prevalência e MI por CC na Europa de 2000 a 2005
gisa_legal
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
Xiaoming Zeng
 
American Holocaust
American HolocaustAmerican Holocaust
American Holocaust
Ray Gebauer
 

Similar to rachelslides.ppt (19)

Coronavirus07
Coronavirus07Coronavirus07
Coronavirus07
 
Thyroid
Thyroid Thyroid
Thyroid
 
Lung cancer: “Epidemiology and risk factors”
Lung cancer: “Epidemiology and risk factors”Lung cancer: “Epidemiology and risk factors”
Lung cancer: “Epidemiology and risk factors”
 
2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制 2004ASAP從社會福利角度看菸害防制
2004ASAP從社會福利角度看菸害防制
 
Scripps lj grand rounds
Scripps lj grand roundsScripps lj grand rounds
Scripps lj grand rounds
 
Asthma copd bronchitis
Asthma copd bronchitisAsthma copd bronchitis
Asthma copd bronchitis
 
In the year 1900, the maximum number of deaths occurred due to infec.pdf
In the year 1900, the maximum number of deaths occurred due to infec.pdfIn the year 1900, the maximum number of deaths occurred due to infec.pdf
In the year 1900, the maximum number of deaths occurred due to infec.pdf
 
PATIENT SAFETY.ppsx
PATIENT SAFETY.ppsxPATIENT SAFETY.ppsx
PATIENT SAFETY.ppsx
 
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10The Hidden Risk That Is Tearing Your Company Apart   Acbg 3 30 10
The Hidden Risk That Is Tearing Your Company Apart Acbg 3 30 10
 
Respiratory diseases
Respiratory diseasesRespiratory diseases
Respiratory diseases
 
issuebrief_SanchezGerald
issuebrief_SanchezGeraldissuebrief_SanchezGerald
issuebrief_SanchezGerald
 
Prevalência e MI por CC na Europa de 2000 a 2005
Prevalência e MI por CC na Europa de 2000 a 2005Prevalência e MI por CC na Europa de 2000 a 2005
Prevalência e MI por CC na Europa de 2000 a 2005
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
 
Allergic diseases epidemiology, cost of diseases and quality of life
Allergic diseases epidemiology, cost of diseases and quality of lifeAllergic diseases epidemiology, cost of diseases and quality of life
Allergic diseases epidemiology, cost of diseases and quality of life
 
Allergic diseases epidemiology, cost of diseases and quality of life
Allergic diseases epidemiology, cost of diseases and quality of lifeAllergic diseases epidemiology, cost of diseases and quality of life
Allergic diseases epidemiology, cost of diseases and quality of life
 
Introduction to Global Health as an overview
Introduction to Global Health as an overviewIntroduction to Global Health as an overview
Introduction to Global Health as an overview
 
American Holocaust
American HolocaustAmerican Holocaust
American Holocaust
 
RheumaticFever_review.pdf
RheumaticFever_review.pdfRheumaticFever_review.pdf
RheumaticFever_review.pdf
 
Global death causes & preventive strategy
Global death causes & preventive strategyGlobal death causes & preventive strategy
Global death causes & preventive strategy
 

More from NehaPandey199

ch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
ch08%20Integumentary%20System%20The%20Protective%20Covering.pptxch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
ch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
NehaPandey199
 
GriefProcessDeathandDying.pptx
GriefProcessDeathandDying.pptxGriefProcessDeathandDying.pptx
GriefProcessDeathandDying.pptx
NehaPandey199
 

More from NehaPandey199 (20)

roleofnursemanager-201103175440.pptx
roleofnursemanager-201103175440.pptxroleofnursemanager-201103175440.pptx
roleofnursemanager-201103175440.pptx
 
2016 Intro lec2 routes.ppt
2016 Intro lec2 routes.ppt2016 Intro lec2 routes.ppt
2016 Intro lec2 routes.ppt
 
COMMAND FILE.ppt
COMMAND FILE.pptCOMMAND FILE.ppt
COMMAND FILE.ppt
 
bloodkb-160720181259 (1).pptx
bloodkb-160720181259 (1).pptxbloodkb-160720181259 (1).pptx
bloodkb-160720181259 (1).pptx
 
Presentation.pptx
Presentation.pptxPresentation.pptx
Presentation.pptx
 
NUR103ModD.ppt
NUR103ModD.pptNUR103ModD.ppt
NUR103ModD.ppt
 
RTforHealthCareProfessionals.pptx
RTforHealthCareProfessionals.pptxRTforHealthCareProfessionals.pptx
RTforHealthCareProfessionals.pptx
 
Unit_6_COPD_1_.ppt
Unit_6_COPD_1_.pptUnit_6_COPD_1_.ppt
Unit_6_COPD_1_.ppt
 
lesson11.ppt
lesson11.pptlesson11.ppt
lesson11.ppt
 
Google-Keep-Document (1).ppt
Google-Keep-Document (1).pptGoogle-Keep-Document (1).ppt
Google-Keep-Document (1).ppt
 
presentation1-140615135842-phpapp02.pptx
presentation1-140615135842-phpapp02.pptxpresentation1-140615135842-phpapp02.pptx
presentation1-140615135842-phpapp02.pptx
 
Mar 3 2004.PPT
Mar 3 2004.PPTMar 3 2004.PPT
Mar 3 2004.PPT
 
Lecture_3.pptx
Lecture_3.pptxLecture_3.pptx
Lecture_3.pptx
 
Chapter 16 jk.pptx
Chapter 16 jk.pptxChapter 16 jk.pptx
Chapter 16 jk.pptx
 
Lecture 5_M08_KARR120_10E_PPT_C08.ppt
Lecture 5_M08_KARR120_10E_PPT_C08.pptLecture 5_M08_KARR120_10E_PPT_C08.ppt
Lecture 5_M08_KARR120_10E_PPT_C08.ppt
 
AM_EXERCISE.ppt
AM_EXERCISE.pptAM_EXERCISE.ppt
AM_EXERCISE.ppt
 
NUR201-ModuleGSlides.pptx
NUR201-ModuleGSlides.pptxNUR201-ModuleGSlides.pptx
NUR201-ModuleGSlides.pptx
 
ch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
ch08%20Integumentary%20System%20The%20Protective%20Covering.pptxch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
ch08%20Integumentary%20System%20The%20Protective%20Covering.pptx
 
GriefProcessDeathandDying.pptx
GriefProcessDeathandDying.pptxGriefProcessDeathandDying.pptx
GriefProcessDeathandDying.pptx
 
ICU-Triage.ppt
ICU-Triage.pptICU-Triage.ppt
ICU-Triage.ppt
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
heathfieldcps1
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Recently uploaded (20)

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 

rachelslides.ppt

  • 1. R A C H E L P R Y O R E P I D 6 9 1 F E B R U A R Y 2 5 , 2 0 1 3 Asthma and COPD
  • 2. What is asthma?  Disorder of the airways causing swelling and narrowing; which leads to wheezing, shortness of breath, chest tightness, and coughing  Most common asthma triggers: dust, animal dander, weather changes, pollution, mold, pollen, respiratory infections, stress, tobacco smoke  There is no cure for asthma.  http://www.ncbi.nlm.nih.gov/pubmedhe alth/PMH0001196/
  • 3. Four categories of asthma  According to the National Heart, Lung, and Blood Institute the four categories are:  1. Intermittent - daytime symptoms that occur less than two times/week and nighttime symptoms occur less than two times/month. Normal pulmonary function tests (PFT).  2. Mild persistent - daytime symptoms occurring two or more times/week and nighttime symptoms occurring two or more times/month. Normal PFT.  http://virginiaasthmacoalition.org/documen ts/AsthmaPlan.8.30.10.pdf  3. Moderate persistent - daily daytime symptoms and at least one weekly nighttime symptom, and/or PFT reduced to 60 – 80% of normal.  4. Severe persistent - continuous daytime symptoms and frequent night symptoms and PFT that may be less than 60% of normal.  National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program (2007). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
  • 4. Asthma: Incidence and Prevalence  18.9 million adults, or 8.2% of the adult population, in the U.S. have asthma  7.1 million children, or 9.5% of children, in the U.S. have asthma  http://www.cdc.gov/nchs/fastats/asthma.htm  Incidence of asthma in adults is 3.8/1000 at-risk adults  Incidence of asthma in children is 12.5/1000 at-risk children  Among children 0-4 years old, incidence is 23.4/1000 children!  Winer, Rachel A., Xiaoting Qin, B.A., Harrington, Theresa, Moorman, Jeanne, Zahran, Hatice. Asthma Incidence among Children and Adults: Findings from the Behavioral Risk Factor Surveillance System Asthma Call-back Survey—United States, 2006–2008. Asthma, February 2012, Vol. 49, No. 1 , Pages 16-22 (doi:10.3109/02770903.2011.637594).
  • 6. Asthma Prevalence by Race/Ethnicity  http://www.cdc.gov/mmwr/preview/mmwrhtml/su6001a18.htm?s_cid=su6001a18_w#tab
  • 7. Asthma Prevalence by Sex and Race
  • 8. Asthma Prevalence by SES and Race
  • 9. More statistics  Number of deaths caused by asthma (in 2010): 3,404  1.1/100,000 of the population  Number of outpatient visits per year with asthma as primary diagnosis (in 2009): 1.2 million  Number of ED visits with asthma as primary diagnosis (in 2009): 2.1 million  Number of hospital discharges with asthma as first-listed diagnosis (in 2009): 479,000  Average length of stay: 4.3 days  http://www.cdc.gov/nchs/fastats/asthma.htm
  • 10. The incidence of asthma is increasing  From 2001 – 2009, the incidence of asthma increased by 4.3 million  Rates grew the most (almost a 50% increase!) among black children  Why?  Hygiene hypothesis: we’re “too clean”  Sedentary lifestyle: decreases lung strength  Obesity: increases overall inflammatory response of the human body  Changes in immune system as we “modernize”  http://www.scientificamerican.com/article.cfm?id=why-are-asthma-rates-soaring
  • 11. The cost of asthma  Medical expenses per person per year is $3300 on average.  40% of uninsured people could not afford their asthma-related medications, and 11% of insured people could not afford their asthma- related medications between 2002-2007.  Asthma costs in the US in 2002 were approximately $53 billion – in 2007 they were approximately $56 billion.  59% of children and 33% of adults with asthma missed school or work due to asthma in 2008.  On average, children missed 4 days of school and adults missed 5 days of work because of asthma  http://www.cdc.gov/VitalSigns/Asthma/i ndex.html
  • 12. Asthma and Public Health  There are many public health initiatives in place to reduce asthma exacerbations  Community Preventative Services Task Force’s initiative “Asthma Control: Home Based Multi Trigger, Multicomponent Environmental Interventions”  Home visits are conducted by a trained person to assess home environments and educate families about what can be done to decrease asthma triggers and also how to better self-manage one’s asthma  http://www.thecommunityguide.org/asthma/multicomponent.html
  • 13. Public Health Initiatives cont.  Healthy People 2020 goal: “Promote respiratory health through better prevention, detection, treatment, and education efforts”  Specific objectives: http://www.healthypeople.gov/2020/topicsobjectives2020/o bjectiveslist.aspx?topicId=36  “Increase the number of States, Territories, and the District of Columbia with a comprehensive asthma surveillance system for tracking asthma cases, illness, and disability at the State level”  No Virginia data on the CDC website! http://www.cdc.gov/asthma/stateprofiles.htm  http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=36
  • 14.  In 2008, less than half of the people diagnosed with asthma reported being taught how to avoid triggers.  48% of adults who were taught about trigger avoidance did not follow most of their doctor’s teaching.  http://www.cdc.gov/VitalSigns/Asthma/index.html#StateInfo
  • 15. Asthma in Virginia  In 2010, the Virginia Asthma Coalition released a plan for Virginia  And VDH does track Virginia data (though the last comprehensive report was written in 2007, using data through 2004)  7.3% of adults (412,370 people) in Virginia have asthma  9% of children (152,277 people) in Virginia have asthma  In 2004, total cost of asthma hospitalizations in Virginia was $96 million! (which was a 58% increase from 1999)  https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
  • 16. Asthma in Virginia  Current asthma rates in Virginia have slightly increased since 2000 (average in 2000 was 7.1%, in 2008 it was 9.3%) https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
  • 17. Virginia compared to the US https://www.vdh.virginia.gov/news/PressKits/Asthma/Overview.pdf
  • 21. Research Needs  According to the EPA, some of the most important areas of research related to asthma include:  More information about the induction and exacerbation of asthma  Why the incidence of asthma is increasing  What factors make one more susceptible to asthma  Risk assessment of environmental pollutants and asthma  http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=54825
  • 22. What is COPD?  COPD is Chronic Obstructive Pulmonary Disease and is characterized by diseases that cause airflow blockage and problems related to breathing.  It includes emphysema, chronic bronchitis, and asthma (in some cases).  COPD is caused by:  Tobacco exposure  Asthma  Air pollutants  Genetic factors  Respiratory infections  http://www.cdc.gov/copd/
  • 23. Chronic bronchitis vs. emphysema  Chronic bronchitis is characterized by a long-term cough with mucous production  Emphysema is characterized by destruction of the lungs overtime
  • 24. COPD: Prevalence  There is a vast under-diagnosis of COPD.  6.3% of American adults (approximately 15 million people) have been diagnosed with COPD.  In adults aged 18-44, 3.2% of the population has been diagnosed with COPD.  In adults ages 65 and older, 11.6% have been diagnosed with COPD.  White adults have the highest rate of COPD (6.3%).  6.1% of black adults and 4.3% of Hispanic adults have COPD.  9.5% of those with COPD did not have a high school diploma  http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm#fig
  • 25. • In 2008, 9.8 million adults were diagnosed with chronic bronchitis. • In 2008, 3.8 million adults reported having ever been diagnosed with emphysema. • Surprisingly (to me), more women than men suffer from these diseases. • http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
  • 26. Age-adjusted prevalence of COPD among adults
  • 27. COPD in Virginia  Chronic bronchitis is the second leading hospital discharge diagnosis in Virginia.  Emphysema is the seventh leading hospital diagnosis in Virginia.  http://www.vapremier.com/index.php?page=copd-management-program
  • 29. Morbidity and mortality  The estimated cost of COPD in 2010 was $49.9 billion.  $29.5 billion related to direct hospital costs, $8 billion on indirect morbidity costs, and $12.4 billion on indirect mortality costs  COPD is the third leading cause of death in the USA, claiming 124,477 lives in 2007.  672,000 hospitalizations in 2006 were due to COPD.  http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html
  • 30. Disparities and COPD  More Caucasians than African Americans have chronic bronchitis (50.8 per 1000 vs. 38.6 per 1000).  Rate among Hispanics only 20.6 per 1000.  The same is true of emphysema (21.1 per 1000 Caucasians vs. 8.1 per 1000 African Americans vs. 6.3 per 1000 Hispanics)  Among the uninsured, African Americans were significantly less likely than Caucasians to receive a lung transplant (61 vs 68%)  50.5 per 100,000 White men died from COPD in 2006  Death rate for White women was 39.1 per 100,000  Death rate for Black men was 37.7 per 100,000  Death rate for Black women was 18.9 per 100,000  http://www.lung.org/assets/documents/ publications/solddc-chapters/copd.pdf
  • 31.
  • 32. Public Health Research and COPD  Access to healthcare is a huge obstacle for Hispanics who suffer from COPD  Studies who that they are twice as likely as Caucasians to utilize the ER for management of their COPD  Words such as wheeze and dyspnea do not translate well into Spanish  Hispanics are often grouped all together, rather than being treated as people from various countries  More research needs to be done to define subgroups of Hispanics and their relationship to the healthcare system in the United States  http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
  • 33. Public Health Research and COPD  Very limited information has been collected about Asian Americans, Native Americans, and Native Pacific Islanders and the prevalence of COPD among these groups  http://www.lung.org/assets/documents/publications/solddc-chapters/copd.pdf
  • 34. Healthy People 2020 and COPD  Reduce activity limitations among adults with chronic obstructive pulmonary disease (COPD)  Reduce deaths from chronic obstructive pulmonary disease (COPD) among adults  Reduce hospitalizations for chronic obstructive pulmonary disease (COPD)  Reduce emergency department (ED) visits for chronic obstructive pulmonary disease (COPD)  Increase the proportion of adults with abnormal lung function whose underlying obstructive disease has been diagnosed  http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=36
  • 35. COPD Asthma  Rarely occurs before age 45  Rarely occurs in a non- smoker  Little can be done to improve sx. of COPD once patients experience them  COPD patients rarely go a day without experiencing sx.  Lung function never returns to normal  Can occur with asthma  Can occur at any age  Can occur in a smoker or non-smoker  Removing environmental triggers can greatly improve asthmatic sx.  Asthmatics can go great lengths of time in between experiencing sx.  Lung function returns to normal between attacks Asthma vs. COPD COPD is often misdiagnosed as asthma, which leads to ineffective treatment and management. (http://copd.about.com/od/fa1/a/asthmaorcopd.htm)
  • 36. SMOKING CESSATION IS KEY!  85 to 90% of COPD deaths are caused by smoking.  Smokers are 12% (in men) and 13% (in women) more likely to die from COPD than non-smokers.  http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html  Smokers likelihood of developing COPD is 50%.  Risk of COPD decreased by 50% after quitting smoking.  Laniado-Laborín, Rafael . Smoking and Chronic Obstructive Pulmonary Disease (COPD): Parallel Epidemics of the 21st Century. International Journal of Environmental Research and Public Health, 2009, 6, 209-224; doi:10.3390/ijerph6010209.

Editor's Notes

  1. The results of this analysis are subject to at least four limitations. First, the asthma prevalence estimates in this report rely on self-report and are subject to recall bias. The respondent must correctly recall a physician diagnosis of asthma, which in turn requires that the physician diagnosis was correct and that the diagnosis was conveyed to the person. Because no definitive test exists for asthma, the diagnosis and self-report cannot be validated; however, a 1993 review of asthma questionnaires documented a mean sensitivity of 68% and a mean specificity of 94% when self-reported information on an asthma diagnosis was compared with a clinical diagnosis (1). Second, common to the majority of survey data, results might be biased because of response rates. NHIS is conducted by personal interview and had household response rates between 85% and 87% for the years included in this report. Third, because NHIS includes only the civilian, noninstitutionalized population of the United States, results might not be representative of other populations. Finally, because NHIS is conducted only in English and Spanish, results might not be representative of households whose residents have other primary languages.
  2. Highest are Chesapeake and Lenowisco. Richmond is second highest with 10.8!
  3. This is the first report of state-specific prevalence of COPD among adults in all 50 states, DC, and Puerto Rico; all data is self-reported!
  4. Very little epidemiological data re: copd, no incidence of emphysema found